Neofact® - Medical device for surfactant application

Neofact® - Medical device for surfactant application
Product Description

Neofact is an innovative applicator for instillation of surfactant and is used for the management of respiratory distress syndrome (RDS) in preterm and term neonates:

  • Simple and practical handling
  • Application of surfactant without Magill forceps
  • Precise positioning in front of the glottis

About Neofact:

  • Medical device class IIa
  • CE certified
  • 55 cm catheter
  • 3.5 FR catheter

Watch a video on the use of Neofact here:  https://www.lyomark.com/neofact/

Lyomark Pharma GmbH

  • DE
  • 2015
    On CPhI since
Specifications

Lyomark Pharma GmbH

  • DE
  • 2015
    On CPhI since

More Products from Lyomark Pharma GmbH

  • Manufacturing Services

    Product Manufacturing Services

    Lyomark Pharma Ltd offers a wide range of services which includes manufacturing services. It has been working for many years with reliable and internationally operating contract manufacturers. Each product is constantly accompanied by the development, on the approval and production to ready-made sales of goods. It regularly audited its suppliers to ensure the consistently high quality of products. Through years of market knowledge and expertise of employees in the field of contract manufacturing to get customized services for product and your market. It includes a pharmaceutical formulation development service; development from pilot scale to validated commercial batch size. Contact us for more information.
  • Active ingredients Service

    Product Active ingredients Service

    Lyomark Pharma Ltd offers a wide range of services which includes active ingredients service. It collaborates with leading pharmaceutical manufacturers from around the world in the development and marketing of pharmaceutical raw materials and active ingredients. It helps to market analysis and choosing the right supplier and provides access to a comprehensive range of active pharmaceutical ingredients including the necessary documentation, such as cep and edmf.. Contact us for more information.
  • Regulatory Services

    Product Regulatory Services

    Lyomark Pharma Ltd offers a wide range of services which includes regulatory services. It offers different regulatory services to clients from the pharmaceutical industry. In addition to the provision of our products and the dossiers based on submission of approvals and following further services are available such as product quality review (pqr)-the creation of the pqr, the intervals respectively desired if necessary, to. Alternatively, the raw data for their own creation of the pqr be provided. Database query-performs at desired intervals through regular polling of relevant databases. Periodic safety update report (psur)- the psur to the respective desired intervals and prepare it on submission requirements. If desired, also internal company data are implemented.. Contact us for more information.
  • Distribution Services

    Product Distribution Services

    Lyomark Pharma Ltd offers a wide range of services which includes distribution services. It distributes since 2007 its own products directly in the german hospital market. In addition to direct sales in germany will award it also has distribution licenses to international distribution partner for the worldwide distribution of pharmaceutical products. Contact us for more information.
  • Alveofact® - Natural bovine lung surfactant

    Product Alveofact® - Natural bovine lung surfactant

    Alveofact is used in neonates. Preventive use in premature neonates with a high risk of respiratory distress syndrome (RDS).
    Active substance: Phospholipid fractionfrom bovine lung (surfactant)
  • Vancomycin

    Product Vancomycin

    Vancomycin Lyomark 500 mg and 1000mgPowder for concentrate for solution for infusion or oral solution.
  • Somatostatin Lyomark

    Product Somatostatin Lyomark

    Somatostatin 3mg

    Powder for solution for infusion
  • NeoKay® - Vitamin K1 prophylaxis

    Product NeoKay® - Vitamin K1 prophylaxis

    NeoKay® is a medicinal product used for the prophylaxis of vitamin K1 deficiency bleeding in healthy infants from the 36th week of gestation.
    Each soft capsule contains 1 mg phytomenadione (vitamin K1).

    Pack sizes of 12s (retail) and 100s (hospital) are available.


    Shelf life:3 years
    After opening: 12 weeks
  • Octreotide

    Product Octreotide

    Octreotid Bendalis 0.05 mg/ml
    Octreotid Bendalis 0.1 mg/ml
    Octreotid Bendalis 0.5 mg/ml
    Octreotid Bendalis 0.2 mg/ml



  • Neofact - Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)

    Product Neofact - Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)

    Neofact, by Lyomark Pharma, is a medical device for neonates suffering from RDS. 
    This study shows that the LISA method (less invasive surfactant administration) via Neofact® appears feasible. 

    Neofact® makes surfactant application easy and is also suitable for all gestational ages. This was confirmed in the study and the results of the study are convincing.An extremely high success rate could be achieved (95%).


    https://pubmed.ncbi.nlm.nih.gov/33023914/

Lyomark Pharma GmbH resources

Recommended products